Health

Breakthrough for Anavex: Phase IIB/III Trial Reveals Potential in Early Alzheimer’s Treatment

14
Breakthrough for Anavex

Anavex Life Sciences has announced results from their ANAVEX2-73-AD-004 Phase IIB/III trial, evaluating the efficacy and safety of blarcamesine (ANAVEX…

Read More »
Back to top button